Recent studies implicate NETs as key players in SLE pathogenesis12, and focusing on circulating NETs (mostly NETs, and might also be monocyte and macrophage extracellular traps (METs)13), which can be measured by MPO-DNA complex levels, can be an important clue for patient stratification prior to treatment. The gene discussed is MPO; the disease is systemic lupus erythematosus.